Coronavirus

Stanford creates virtual scientist to accelerate drug and vaccine discovery

Stanford researchers have developed an AI-powered "virtual scientist" capable of designing drug and vaccine candidates, marking a leap forward in biomedical research.

Uptake of existing vaccines will help support health systems from COVID-19 pressures

The Immunisation For All Ages group discusses the importance of protecting vaccine budgets and immunisation infrastructure, even amidst COVID-19.

Research and innovation in Europe

The role of research and innovation in Europe, including the challenge COVID-19 brings to the sector, the principles of Open Access, increased cross-border collaboration plus gender and diversity, are discussed here.

A path to green transport in Europe

Open Access Government discusses Commissioner for Transport Adina Vălean’s priorities for digital and green transport in Europe amidst COVID-19.

How content design will convert the ‘volunteer army’

Jack Perschke, Partner at Netcompany, believes that app and content design is key to capturing the public's capacity for kindness and converting it to an engaged, willing volunteer base.

Circulatory and respiratory health in Canada

Open Access Government looks into the current research priorities and initiatives of Canada’s Institute of Circulatory and Respiratory Health (ICRH).

How are social media giants tackling misinformation during COVID-19?

Özlem Bedre-Defolie, Associate Professor of Economics at ESMT Berlin, reflects on how platforms like WhatsApp and Facebook are tackling misinformation at this crucial hour.

Putting people first and strengthening the EU’s Economy

Here, Open Access Government looks into European Commissioner Paolo Gentiloni’s priorities for strengthening the EU’s Economy while also putting citizens first, particularly in a time of crisis.

What are the UK’s priorities for energy policy including electric vehicles today?

Megan Warrender of Open Access Government explores Department for Business, Energy, and Industrial Strategy, led by Rt Hon Alok Sharma MP’s, priorities for energy policy in response to COVID-19.

How will COVID-19 reframe our attitude towards AI ethics?

Vernon Hunte, Associate Director of Public Affairs at April Six, discusses how COVID-19 will change up out attitude towards artificial intelligence (AI) ethics.

5 simple ways to meet new workplace safety standards

Lee Hatwell, director of Munday + Cramer, addresses some of the most frequently asked questions regarding what simple measures can be taken to meet new Government safety standards and ease employee anxieties towards returning to work.

Handling the healthcare impact of COVID-19

Sue Johnson Gregory, principal consultant, and Tim Powlson, senior consultant, at  Entec Si, discuss how the NHS can recover from the long-term impact of COVID-19.

Attracting major investors: GreenLight on the international stage

In the last six months GreenLight Medicines has successfully out-licenced leads from its research, branching out internationally and attracting major investors.

Pilot training in a post COVID-19 reality

Bhanu Choudhrie, Founder of Alpha Aviation, discusses how the aviation industry must adapt in order to overcome challenges in pilot training in a post-COVID-19 world, highlighting the need to address gender imbalances.

The new normal: You have already begun your digital transformation journey

Gaurav Malhotra, Chief Technology Officer at MSC Digital, discusses the logical next steps to continue your digital journey to ensure agility, engagement, and productivity for whatever the post COVID-19 “new normal” turns out to be.

What will COVID-19 mean for child internet safety?

Ian Stevenson CEO at Cyan Forensics discusses what COVID-19 will mean for child internet safety.

Finland: Higher education and research policy priorities

Anita Lehikoinen, Permanent Secretary at the Ministry of Education and Culture describes her policy priorities for higher education in Finland.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders